Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.3M Sell
72,000
-100,000
-58% -$5.78M ﹤0.01% 2066
2025
Q4
$12.8M Buy
172,000
+100,000
+139% +$7.2M ﹤0.01% 1510
2025
Q3
$5.26M Sell
72,000
-100,200
-58% -$7.63M ﹤0.01% 2157
2025
Q2
$11.9M Sell
172,200
-27,800
-14% -$1.44M ﹤0.01% 1453
2025
Q1
$9.04M Sell
200,000
-170,000
-46% -$10.1M ﹤0.01% 1482
2024
Q4
$22.5M Hold
370,000
0.01% 1053
2024
Q3
$15.1M Buy
370,000
+300,000
+429% +$9.95M ﹤0.01% 1219
2024
Q2
$2.11M Buy
+70,000
New +$2.25M ﹤0.01% 2091
2024
Q1
Sell
-1,282,700
Closed -$63M 5050
2023
Q4
$63M Buy
+1,282,700
New +$37.1M 0.02% 569
2023
Q1
Sell
-90,500
Closed -$875K 5066
2022
Q4
$875K Buy
+90,500
New +$1.36M ﹤0.01% 2916
2022
Q3
Sell
-515,000
Closed -$9.3M 4749
2022
Q2
$9.3M Buy
+515,000
New +$14M 0.01% 1043

Other funds holding AFRM

Barclays's AFRM Position: Q1 2026 in Review

Barclays reduced its Affirm (AFRM) stake by 18% in Q1 2026, selling an estimated $2.78M and leaving 219,459 shares worth $10.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1449.

Barclays first reported a position in AFRM in Q1 2022 and has held it in 17 quarters since. The position peaked at $33.6M in Q1 2022. 591 funds tracked by Wall St. Rank hold AFRM as of Q1 2026.

  • Barclays held 219,459 shares of Affirm worth $10.1M as of Q1 2026.
  • Barclays sold 48,169 Affirm shares in Q1 2026, an estimated $2.78M.
  • Affirm made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #1449 holding.
  • Barclays first reported a position in Affirm in Q1 2022 and has held it in 17 quarters since.
  • Barclays's Affirm position peaked at $33.6M in Q1 2022.
  • 591 funds tracked by Wall St. Rank held Affirm as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.